Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report

Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report

Background: Merkel-cell carcinoma (MCC) is a rare, highly aggressive skin cancer typically involving elderly people. Surgery is usually the first treatment for primary tumor. In adjuvant setting, radiotherapy is effective in reducing local recurrence and in improving overall survival. Regarding adva...

Full description

Bibliographic Details
Main Authors: Michele Guida, Alessandro D'Alò, Anita Mangia, Federica Di Pinto, Margherita Sonnessa, Anna Albano, Angela Sciacovelli, Artor Niccoli Asabella, Livia Fucci
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
immunothearpy
somatostatin analog
Merkel cell carcinoma (MCC)
Merkel carcinoma
somatostatin—receptor
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01073/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01073/full

Similar Items